Načítá se...
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
OBJECTIVE: Incident type 2 diabetes is common among patients with recent acute coronary syndrome and is associated with an adverse prognosis. Some data suggest that cholesteryl ester transfer protein (CETP) inhibitors reduce incident type 2 diabetes. We compared the effect of treatment with the CETP...
Uloženo v:
| Vydáno v: | Diabetes Care |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Diabetes Association
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7171952/ https://ncbi.nlm.nih.gov/pubmed/32144166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-2204 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|